Showing results for 'L'
Total number of hits: 21
Click on results for more details:
PDIDL001
L-377202
Active compound: Leurubicin
Indications: Prostate cancer
Target: na
PDIDL001
L-377202
Active compound: Doxorubicin
Indications: Prostate cancer
Target: na
PDIDL002
Lagociclovir valactate
Active compound: 3'-fluoro-2', 3'-dideoxyguanosine
Indications: HBV, HIV (WL1)
Target: Nucleoside reverse transcriptase (WL1)
PDIDL003
Laninamivir octanoate
Active compound: Laninamivir
Indications: Asthma; H1N1 flu
Target: Influenza A/B virus neuraminidase
PDIDL004
Lansoprazole
Active compound: Sulfenamide form of Lansoprazole
Indications: Erosive reflux oesophagitis, active gastric ulcer, active duodenal ulcer, tuberculosis
Target: (H+,K+)-ATPase
PDIDL005
Latanoprost
Active compound: Latanoprost acid
Indications: Open-angle glaucoma or ocular hypertension; intraocular pressure as a result of angle-closure glaucoma
Target: Prostaglandin F2-alpha receptor
PDIDL006
Latanoprostene bunod
Active compound: Latanoprost acid
Indications: Glaucoma
Target: Prostaglandin F2-alpha receptor
PDIDL007
Leflunomide
Active compound: Teriflunomide
Indications: Rheumatoid arthritis (RA) and psoriatic arthritis
Target: Dihydroorotate dehydrogenase (quinone), mitochondrial
PDIDL008
Lefradafiban
Active compound: Fradafiban
Indications: Angina
Target: Human platelet GP IIb/IIIa complex
PDIDL009
Lenampicillin
Active compound: Ampicillin
Indications: Bacterial infections
Target: Enzyme transpeptidase
PDIDL010
Levacetylmethadol
Active compound: Levo-alpha-acetyl-N-normethadol
Indications: Opioid dependence
Target: μ-opioid receptors
PDIDL011
Levodopa
Active compound: Dopamine
Indications: Parkinson's disease and dopamine-responsive dystonia
Target: Dopamine receptor D1, D2, D3, D4, D5 (WL 3)
PDIDL012
Levomethorphan
Active compound: Levorphanol
Indications: Na
Target: Glutamate [NMDA] receptor subunit 3A/3B (Super target)
PDIDL013
Levonorgestrel butanoate
Active compound: Levonorgestrel
Indications: Injectable contraceptive
Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 1; Progesterone receptor; Estrogen receptor alpha
PDIDL014
Lisdexamfetamine
Active compound: D-amphetamine
Indications: Attention Deficit Disorder With Hyperactivity (ADHD); Binge Eating Disorder (BED)
Target: Trace amine-associated receptor 1 (Drug Bank); Alpha-1B adrenergic receptor (Therapeutic Target Database)
PDIDL015
Loperamide Oxide
Active compound: Loperamide
Indications: Diarrhea
Target: μ-opioid receptors
PDIDL016
Loratadine
Active compound: Desloratadine
Indications: Seasonal allergic symptoms (R1)
Target: H1 histamine receptor
PDIDL017
Lovastatin
Active compound: Lovastatin acid
Indications: Hypercholesterolemia
Target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase)
PDIDL018
Loxoprofen
Active compound: Loxoprofen trans-OH metabolite
Indications: Musculoskeletal and joint disorders
Target: Prostaglandin G/H synthase 2; Prostaglandin G/H synthase 1
PDIDL019
LY2140023
Active compound: LY404039
Indications: Psychosis and schizophrenia
Target: Metabotropic glutamate receptor 2; Metabotropic glutamate receptor 3
PDIDL020
Lynestrenol
Active compound: Norethisterone
Indications: Menorrhagia; Metrorrhagia; Myomas; Chronic hip pains; Dysmenorrhea (R1); 2) Hepatic Disease; Vaginal Bleeding; Myocardial Infarction; Vascular Disease; Deep vein thrombosis (R 2)
Target: Progesterone receptor